We are live on
!
Find out more
NERM
New England Research & Management Portfolio holdings
AUM
$257M
1-Year Est. Return
25.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$119M
AUM Growth
+$3.11M
(+2.7%)
Cap. Flow
+$619K
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.99%
Holding
184
New
25
Increased
49
Reduced
67
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$881K |
| 2 |
Darden Restaurants
DRI
|
+$766K |
| 3 |
United Rentals
URI
|
+$730K |
| 4 |
Installed Building Products
IBP
|
+$692K |
| 5 |
Aecom
ACM
|
+$691K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.48M |
| 2 |
Analog Devices
ADI
|
+$1.13M |
| 3 |
PRXL
Parexel International Corp
PRXL
|
+$1.1M |
| 4 |
Microsoft
MSFT
|
+$969K |
| 5 |
JWN
Nordstrom
JWN
|
+$833K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.45% |
| 2 | Healthcare | 16.9% |
| 3 | Consumer Staples | 13.84% |
| 4 | Financials | 13.02% |
| 5 | Consumer Discretionary | 11.59% |
Similar funds
GCCM
EBWM
HFRG
ACM
CCA
PHAM
TC
New England Research & Management's Q3 2016 Portfolio in Review
As of Q3 2016, New England Research & Management held 184 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
New England Research & Management's Q3 2016 filing shows 25 new, 49 increased, 67 reduced and 21 closed positions. Its largest new stake was Installed Building Products: 19,900 shares worth $714K. The largest sale was Merck, an estimated $1.48M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.
- New England Research & Management's largest Q3 2016 buy was Installed Building Products: 19,900 shares worth $714K.
- New England Research & Management added most to Bristol-Myers Squibb in Q3 2016, an estimated $881K increase.
- New England Research & Management's biggest Q3 2016 reduction was Merck, cutting an estimated $1.48M.
- New England Research & Management fully exited Analog Devices in Q3 2016, selling an estimated $1.13M.
- New England Research & Management's ten largest holdings make up 23% of its $119M portfolio in Q3 2016.
- New England Research & Management opened 25 new positions and closed 21 in Q3 2016.
- New England Research & Management's portfolio value rose 2.7% quarter-over-quarter to $119M.
Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.